Horizon Therapeutics Financial Health
How is Horizon Therapeutics's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: HZNP's short term assets ($3.2B) exceed its short term liabilities ($791.1M).
Long Term Liabilities: HZNP's short term assets ($3.2B) exceed its long term liabilities ($3.1B).
Debt to Equity History and Analysis
Debt Level: HZNP's net debt to equity ratio (13.6%) is considered satisfactory.
Reducing Debt: HZNP's debt to equity ratio has reduced from 184% to 51.9% over the past 5 years.
Debt Coverage: HZNP's debt is well covered by operating cash flow (55.1%).
Interest Coverage: HZNP's interest payments on its debt are well covered by EBIT (11x coverage).